Position in GRFS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,582
-$1,538 QoQ
Shares Held
1,636
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#124
of 164 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Smartleaf Asset Management LLC holds $62,469,605 across 16 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,989 | $16,778,827 | |
| 2 | JNJ |
Johnson & Johnson
|
56,007 | $14,224,097 | |
| 3 | ABBV |
AbbVie Inc.
|
36,739 | $9,245,001 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,005 | $5,140,642 | |
| 5 | AMGN |
Amgen Inc
|
8,416 | $3,047,601 | |
| 6 | NVS |
Novartis AG
|
17,483 | $2,739,935 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
20,414 | $2,579,104 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
39,356 | $2,267,692 |
All Filings in GRFS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,582 | 1,636 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $13,120 | 1,636 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,279 | 2,062 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,768 | 278 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $678 | 75 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $14,049 | 1,976 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,901 | 1,062 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $4,297 | 484 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,858 | 453 | Shares | Sole | 2024-10-08 | |
| 2024-03-31 | $1,429 | 214 | Shares | Sole | 2024-10-07 | |
| No filing history on record for this holder in this stock. | ||||||